Standalone vs stacked amylin agonist use after GLP-1 therapy: dosing, mechanisms and long-term questions

That's accurate. Yet most of my drop happened during the opening quarter. Over the recent half year the scale stayed fixed near 105 kilograms. Adding that extra item got a modest decline going once more. Another fifteen or twenty kilograms would bring me to a suitable level. I switched to Tirz after quitting Reta to fix the high blood sugar problem. Things seem to move along better under the present setup.

My doctor started me on this one after my plan denied coverage for the other type of meds. I only stuck with it for seven days because the stomach problems hit harder than anything else I've taken before.

From what I've seen in my own small trial, the dropout percentage seems tied more to unwanted effects instead of the quick shedding of pounds. I expect we'll get clearer insights once the numbers get looked over, hopefully with some personal stories included.

The dosing frequency lines up with weekly use for those compounds mainly because following instructions consistently matters more than hitting peak performance. Most people just aren't great at keeping up with their prescriptions on schedule. Switching to something like every ten days or longer would cause mistakes almost right away for plenty of folks, starting after the first dose. That points to why some prefer less regulated choices, even if solid medical supervision still can't get everyone to stick with it properly.

These GLP-1 options appear intended for permanent daily use. The products focused on amylin remain unclear to me. I would rather not attempt any speculation.

I figure these amylin things work much like the others since they manage weight issues without fixing the root cause, so folks probably stay on them indefinitely. What stands out though is how amylin can make the body respond better to leptin again in people carrying extra weight, and that hormone plays a central role in keeping fat levels steady over the long haul. One key detail here is that the problem with leptin in obesity isn't usually about having too little of it around, since levels tend to sit at normal or higher amounts, but rather the system stops reacting properly after a while. Amylin seems to adjust that reaction point lower, getting things working again in the relevant brain spots and leading to steadier results with weight. Research on keeping weight off also points to better outcomes when using amylin together with those other agents compared to using them by themselves. Pair that with how it might help push past sticking points in progress, and that could be where the biggest potential shows up.

Appreciate the response! That part about the leptin sensitivity limit really stands out to me. My interest in leptin came from wanting to know how to bring down a person's weight set point, and adjusting leptin activity appears to be a reasonable approach. It's still uncertain whether that drug or similar amylin agents can really pull it off. To make my previous comment clearer, the best human data on adding amylin applies to the treatment phase itself, not just the keeping-it-off stage. The keeping-it-off upside I referred to originated in lab animal work, which means I ought to highlight that separation better. Sadly, there are few strong human trials looking at the top methods for staying at goal weight... so we're left without much guidance on it. 😂

You're the best tester out of everyone in this community. Truly the most dedicated experimenter. The pioneer who started it all. Glad you posted what happened. I like watching how it goes. Thanks a lot.

True, things stay unclear for now. Still the sleepless nights from reta cut down on rest and open up extra hours for lifting, funny enough. The group picks up a side benefit on leptin control.

Things seem uncertain with little known about amylin and leptin so far. I tried not to exaggerate how well these agonists might control weight over time. Still, big drug companies show strong interest in developing amylin agonists overall. A chart in a new Nature article covers fresh drug work on treating obesity. It shows every amylin agonist currently being developed. The amount of money poured into this approach caught me off guard. I hope it offers benefits beyond simply reducing hunger. Though that idea might just be optimistic.

I have come across test documents from two places, though I have not personally viewed any structural confirmation even if they are out there.

The reports from that lab appear with a note confirming the structure is correct.

My take is there is space for more than one option to succeed. People differ widely in tolerance, so some will respond well to one approach and poorly to another, which already allows several products to coexist. Beyond that, the actual business strategy centers on combinations rather than single agents, since each firm wants its own asset to pair with its existing compound and keep the full package under its control. The overall demand is also large enough and supply limited enough that one player cannot cover everything. None of this suggests every listed compound will survive, but several could.

We already have that advance available through current medications. Sustained weight reduction over long periods is not something waiting in the future. Data from one large trial show this clearly. I am convinced ongoing weight control can be achieved with these treatments. The only reason the line rises again later in the study is that participants stopped the medication. There is no basis to expect the flat portion would have changed without that step. Adding another agonist could push the plateau lower, which would mean the weight-loss side of the condition is effectively handled. I recall a company leader saying something along those lines in a call. This is not a permanent fix though, since continued use would still be needed, possibly involving more than one agent. By the way, I hope this holds because I have already given away a lot of larger clothing.

Right, I left that part out. With ongoing use of the current class you can maintain the loss, but I am thinking more about a direct comparison between someone who was previously overweight and someone who never was. What I have in mind is reaching a point where the baseline resets as though the extra weight had never been there.

A few details stood out. Everyone received coaching on food and movement. Some on the highest tolerated amount who regained were given more of the compound, and the same happened at the lower tested level. I wonder if that overlaps with people already considered at their maximum tolerated amount.

Nearly every trial I have looked at supplies the same coaching on food and activity, so the longer studies are not different in that respect. Even those on placebo kept a small reduction, probably from the coaching and maybe some optimism. The idea of an added dose later is interesting but comes from a separate trial than the one shown. The one shown kept everyone on the same amount throughout. Here is what the procedures were.

That is interesting. The one I located was a maintenance-focused trial, so yours is clearly a different one.

Quite a few people on this site and similar places push back against the idea of keeping a steady food deficit and increasing movement. They expect the medication to handle everything so they can continue with their usual intake and just raise the amount if needed. Then one particular commenter always brings up deficits, energy balance, and activity. I enjoy those comments even when others reply that they are already eating clean.

The paper covers three years of treatment in people with obesity and prediabetes and reports substantial sustained reduction along with much lower risk of developing type 2 diabetes compared with placebo.

I was surprised to see I posted right after that same person in a different thread where someone was adding back exercise calories and no comment was made.

I figured out years ago that many people simply have no interest in tracking intake, weighing portions, or checking labels, and no amount of encouragement will change that. At the core, weight reduction still needs a deficit. It is good that the commenter supports food and activity habits. I do not emphasize it as strongly, not because I disagree, but because each person should pick what fits them. I do not need to make my approach theirs.

I agree on the surface, yet it is difficult to stay silent when someone hits a plateau. I am actually more worried when they are not tracking nutrition while still losing on very calorie-dense choices. I found it difficult to hit fiber, fat quality, and protein targets even while tracking.

I did notice it mentally as well. I also appreciated the point because many do not realize how much daily energy needs can drop with age from lower muscle and general activity.

I do know exactly what and how much I eat, yet without physically recording everything I will regain even while using these medications. The difference is I am no longer constantly hungry. I could still snack from boredom if I did not know it would go in the record. I have lost every week. Restricting is not draining for me, but it remains a deliberate decision. Maybe because I have never gone high enough to feel sick from food or the idea of eating. I have a child, cook daily, and eat normal mostly healthy food most of the time while staying inside my budget.

If the current routine works, can be kept up, and does not involve constant strong hunger, then even if recording is required it is still effective. My worry with deficit and tracking approaches in general is how poorly they hold up over years, since keeping intake below what the body signals is tiring and most eventually cannot maintain the effort and regain. That was basically the pattern before these medications. In many ways the best situation, when possible and without side effects or needing the highest amounts, would be adjusting so the deficit happens without constant deliberate effort, because that state would be sustainable long term. Achieving it while eating very poor quality food is still not ideal, but in most cases it

I would agree that tracking intake becomes difficult over long periods. Eventually people grow tired of the process. When I began the medication I did not track. I assumed my daily energy use was high enough that simply eating less naturally would produce good results, and it did. Once I had lost a fair amount I recalculated my daily energy use, which had dropped by roughly a thousand calories, and began tracking on weekdays. Having a couple of days without tracking helped. I did that for about six months and learned a great deal about nutrition, portions, and foods that pack many calories. What became clear is it was not surprising I had carried extra weight. My portions were all off. Items I considered healthy were actually high in calories and lower in nutrients than I had thought. I also learned that grazing throughout the day while staying under daily needs is not realistic. I no longer track, yet weight keeps dropping. I focus on two main meals plus a smaller third meal and two snacks. That is it. I try to keep portions in line with what I remember from tracking.

This point often gets missed and matters a lot. Halfway through my own reduction phase I recalculated and updated my daily energy needs.

Thanks for keeping us posted. I started my first dose on Sunday at one milligram so any positive note is welcome and too rapid sounds good to me. I have been stuck at the top amount of another compound for nearly a year.

I bet you do not believe in gravity either.

Who claims anyone can eat whatever they want? That does not sound right.

I am about to start this week. Thanks for sharing what you experienced.